HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Brada Selected Research

Drug Therapy (Chemotherapy)

1/2018Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer.
6/2005Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide.
12/2003Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
5/2002Temozolomide as second-line chemotherapy for relapsed gliomas.
9/2000A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
4/2000Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Brada Research Topics

Disease

9Glioma (Gliomas)
09/2006 - 01/2000
6Brain Neoplasms (Brain Tumor)
05/2015 - 10/2000
5Pituitary Neoplasms (Pituitary Adenoma)
06/2009 - 06/2000
5Glioblastoma (Glioblastoma Multiforme)
06/2005 - 04/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 11/2008
3Neoplasms (Cancer)
05/2015 - 09/2000
3Meningioma (Meningiomas)
10/2012 - 03/2000
3Astrocytoma (Pilocytic Astrocytoma)
06/2005 - 09/2000
2Neoplasm Metastasis (Metastasis)
05/2015 - 01/2001
2Adenoma (Adenomas)
05/2006 - 06/2000
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Type 2 Diabetes Mellitus (MODY)
12/2013
1Weight Gain
12/2013
1Retinal Artery Occlusion
10/2012
1Oligodendroglioma
12/2003
1Epilepsy (Aura)
12/2003
1Hypopituitarism (Sheehan's Syndrome)
12/2002
1Hydrocephalus (Hydrocephaly)
04/2002
1Cognitive Dysfunction
04/2002
1Thrombocytopenia (Thrombopenia)
02/2001
1Fatigue
10/2000
1Pain (Aches)
10/2000
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2000
1Lymphoma (Lymphomas)
09/2000
1Vision Disorders (Hemeralopia)
06/2000
1Hemianopsia (Bitemporal Hemianopsia)
06/2000

Drug/Important Bio-Agent (IBA)

7Temozolomide (Temodar)FDA LinkGeneric
02/2004 - 04/2000
3Hormones (Hormone)IBA
06/2009 - 06/2000
2Adrenal Cortex Hormones (Corticosteroids)IBA
10/2000 - 06/2000
2Procarbazine (Matulane)FDA Link
09/2000 - 04/2000
1Paclitaxel (Taxol)FDA LinkGeneric
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1vistusertibIBA
01/2018
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2013
1VildagliptinIBA
12/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2013
1Metformin (Glucophage)FDA LinkGeneric
12/2013
1Biological ProductsIBA
02/2012
1Dihydrotachysterol (AT 10)IBA
02/2005
1Protons (Proton)IBA
02/2004
1LipidsIBA
07/2003
1ProdrugsIBA
05/2002
1Thalidomide (Thalomid)FDA Link
01/2001
1Growth Hormone (Somatotropin)IBA
12/2000
1Prednisone (Sone)FDA LinkGeneric
09/2000
1Vincristine (Oncovin)FDA LinkGeneric
09/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2000
1Alkylating AgentsIBA
09/2000

Therapy/Procedure

17Radiotherapy
05/2015 - 03/2000
7Therapeutics
05/2015 - 01/2000
6Drug Therapy (Chemotherapy)
01/2018 - 04/2000
5Conformal Radiotherapy
10/2012 - 06/2000
4Aftercare (After-Treatment)
10/2012 - 06/2000
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2012
1Salvage Therapy
05/2002
1Drug Tapering
02/2001